文献
J-GLOBAL ID:201802262322628547
整理番号:18A0267846
核におけるNFATのレベル増加の手段としてのメリジアニン類から誘導したDYRK阻害剤の開発【Powered by NICT】
Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus
著者 (9件):
Shaw Simon J.
(Rigel Pharmaceuticals, Inc., 1180, Veterans Boulevard, South San Francisco, CA 94080, USA)
,
Goff Dane A.
(Rigel Pharmaceuticals, Inc., 1180, Veterans Boulevard, South San Francisco, CA 94080, USA)
,
Lin Nan
(Rigel Pharmaceuticals, Inc., 1180, Veterans Boulevard, South San Francisco, CA 94080, USA)
,
Singh Rajinder
(Rigel Pharmaceuticals, Inc., 1180, Veterans Boulevard, South San Francisco, CA 94080, USA)
,
Li Wei
(Rigel Pharmaceuticals, Inc., 1180, Veterans Boulevard, South San Francisco, CA 94080, USA)
,
McLaughlin John
(Rigel Pharmaceuticals, Inc., 1180, Veterans Boulevard, South San Francisco, CA 94080, USA)
,
Baltgalvis Kristen A.
(Rigel Pharmaceuticals, Inc., 1180, Veterans Boulevard, South San Francisco, CA 94080, USA)
,
Payan Donald G.
(Rigel Pharmaceuticals, Inc., 1180, Veterans Boulevard, South San Francisco, CA 94080, USA)
,
Kinsella Todd M.
(Rigel Pharmaceuticals, Inc., 1180, Veterans Boulevard, South San Francisco, CA 94080, USA)
資料名:
Bioorganic & Medicinal Chemistry Letters
(Bioorganic & Medicinal Chemistry Letters)
巻:
27
号:
11
ページ:
2617-2621
発行年:
2017年
JST資料番号:
W0248A
ISSN:
0960-894X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)